Biotech | November 26, 2021
Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Owkin builds best-in-class predictive biomedical AI models and robust data sets
Owkin builds best-in-class predictive biomedical AI models and robust data sets
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
_256_384.png)
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
Assam is home to more than 1,700 species of medicinal plants
Barbara Engelhardt moves her computational and statistics lab to Gladstone
In March it launched its first plastic-free toothbrush packaging, which included Sensodyne Pronamel and parodontax brushes in the US. Asia Pacific rollout of this commenced in Australia
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Subscribe To Our Newsletter & Stay Updated
